Oncological applications of somatostatin analogues

Research output: Contribution to journalArticle

514 Citations (Scopus)

Abstract

The potential of modern somatostatin analogues in treatment of a variety of malignancies still remains to be established. However, much experimental and clinical evidence suggests that modern somatostatin analogues could provide a useful palliative form of treatment for some tumors. Somatostatin analogues could be also considered for use as adjuncts to therapy with LH-RH analogues in breast cancer and prostate cancer.

Original languageEnglish
Pages (from-to)6977-6985
Number of pages9
JournalCancer Research
Volume48
Issue number24 I
StatePublished - Dec 1 1988
Externally publishedYes

Fingerprint

Somatostatin
Prostatic Neoplasms
Palliative Care
Gonadotropin-Releasing Hormone
Neoplasms
Breast Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Oncological applications of somatostatin analogues. / Schally, Andrew V.

In: Cancer Research, Vol. 48, No. 24 I, 01.12.1988, p. 6977-6985.

Research output: Contribution to journalArticle

@article{33bf82e77fa04c65a3bf24be5d2a706d,
title = "Oncological applications of somatostatin analogues",
abstract = "The potential of modern somatostatin analogues in treatment of a variety of malignancies still remains to be established. However, much experimental and clinical evidence suggests that modern somatostatin analogues could provide a useful palliative form of treatment for some tumors. Somatostatin analogues could be also considered for use as adjuncts to therapy with LH-RH analogues in breast cancer and prostate cancer.",
author = "Schally, {Andrew V}",
year = "1988",
month = "12",
day = "1",
language = "English",
volume = "48",
pages = "6977--6985",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "24 I",

}

TY - JOUR

T1 - Oncological applications of somatostatin analogues

AU - Schally, Andrew V

PY - 1988/12/1

Y1 - 1988/12/1

N2 - The potential of modern somatostatin analogues in treatment of a variety of malignancies still remains to be established. However, much experimental and clinical evidence suggests that modern somatostatin analogues could provide a useful palliative form of treatment for some tumors. Somatostatin analogues could be also considered for use as adjuncts to therapy with LH-RH analogues in breast cancer and prostate cancer.

AB - The potential of modern somatostatin analogues in treatment of a variety of malignancies still remains to be established. However, much experimental and clinical evidence suggests that modern somatostatin analogues could provide a useful palliative form of treatment for some tumors. Somatostatin analogues could be also considered for use as adjuncts to therapy with LH-RH analogues in breast cancer and prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=0024213731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024213731&partnerID=8YFLogxK

M3 - Article

VL - 48

SP - 6977

EP - 6985

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 24 I

ER -